Phibro Animal Health (PAHC) Tops Q4 EPS by 1c, Offers FY Guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.32, $0.01 better than the analyst estimate of $0.31. Revenue for the quarter came in at $220.3 million versus the consensus estimate of $213.46 million.

GUIDANCE:

Phibro Animal Health sees FY2022 EPS of $1.25-$1.32, versus the consensus of $1.26. Phibro Animal Health sees FY2022 revenue of $840-870 million, versus the consensus of $827.2 million.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal